Sigilon Therapeutics, Syros Pharma, Tessera, Valo, and Vesalius. Paul Biondi, president of Flagship's Pioneering Medicines unit, said the partnership gets underway with "a shared vision of ...
BURLINGAME, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that members of its leadership team ...
After hours: February 12 at 4:42:49 PM EST Loading Chart for CARA ...
Dyne Therapeutics Inc.-5.60% $1.56B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback